Expression and Role of IL-1β Signaling in Chondrocytes Associated with Retinoid Signaling during Fracture Healing
Date
2020Journal
International journal of molecular sciencesPublisher
MDPI AGType
Article
Metadata
Show full item recordAbstract
The process of fracture healing consists of an inflammatory reaction and cartilage and bone tissue reconstruction. The inflammatory cytokine interleukin-1β (IL-1β) signal is an important major factor in fracture healing, whereas its relevance to retinoid receptor (an RAR inverse agonist, which promotes endochondral bone formation) remains unclear. Herein, we investigated the expressions of IL-1β and retinoic acid receptor gamma (RARγ) in a rat fracture model and the effects of IL-1β in the presence of one of several RAR inverse agonists on chondrocytes. An immunohistochemical analysis revealed that IL-1β and RARγ were expressed in chondrocytes at the fracture site in the rat ribs on day 7 post-fracture. In chondrogenic ATDC5 cells, IL-1β decreases the levels of aggrecan and type II collagen but significantly increased the metalloproteinase-13 (Mmp13) mRNA by real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis. An RAR inverse agonist (AGN194310) inhibited IL-1β-stimulated Mmp13 and Ccn2 mRNA in a dose-dependent manner. Phosphorylated extracellular signal regulated-kinases (pERK1/2) and p-p38 mitogen-activated protein kinase (MAPK) were increased time-dependently by IL-1β treatment, and the IL-1β-induced p-p38 MAPK was inhibited by AGN194310. Experimental p38 inhibition led to a drop in the IL-1β-stimulated expressions of Mmp13 and Ccn2 mRNA. MMP13, CCN2, and p-p38 MAPK were expressed in hypertrophic chondrocytes near the invaded vascular endothelial cells. As a whole, these results point to role of the IL-1β via p38 MAPK as important signaling in the regulation of the endochondral bone formation in fracture healing, and to the actions of RAR inverse agonists as potentially relevant modulators of this process.Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082792109&doi=10.3390%2fijms21072365&partnerID=40&md5=a997e52b8286444f6c752f064577b6b0; http://hdl.handle.net/10713/12544ae974a485f413a2113503eed53cd6c53
10.3390/ijms21072365
Scopus Count
Collections
Related articles
- Retinoic Receptor Signaling Regulates Hypertrophic Chondrocyte-specific Gene Expression.
- Authors: Shimo T, Koyama E, Okui T, Masui M, Kunisada Y, Ibaragi S, Yoshioka N, Kurio N, Yoshida S, Sasaki A, Iwamoto M
- Issue date: 2019 Jan-Feb
- Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases.
- Authors: Shimo T, Koyama E, Sugito H, Wu C, Shimo S, Pacifici M
- Issue date: 2005 May
- Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
- Authors: Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H
- Issue date: 2007
- Effects of mesenchymal stem cells on interleukin-1β-treated chondrocytes and cartilage in a rat osteoarthritic model.
- Authors: Tang J, Cui W, Song F, Zhai C, Hu H, Zuo Q, Fan W
- Issue date: 2015 Aug
- All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation.
- Authors: Kirchmeyer M, Koufany M, Sebillaud S, Netter P, Jouzeau JY, Bianchi A
- Issue date: 2008